ESSA Pharma: Q1 Earnings Insights
Portfolio Pulse from Benzinga Insights
ESSA Pharma (NASDAQ:EPIX) reported Q1 earnings on February 13, 2024, beating estimated earnings by 17.65% with an EPS of $-0.14 versus an estimate of $-0.17. However, revenue remained unchanged from the same period last year. In the previous quarter, ESSA Pharma's EPS beat led to a 0.36% increase in share price the following day.
February 13, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ESSA Pharma reported a Q1 EPS of $-0.14, beating estimates by 17.65%, with revenue unchanged from the previous year. Last quarter's EPS beat resulted in a 0.36% stock price increase the next day.
ESSA Pharma's positive earnings surprise of 17.65% is likely to instill investor confidence, potentially leading to a short-term stock price increase, similar to the 0.36% rise observed after the last quarter's earnings beat. However, the unchanged revenue could temper some of the positive sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100